drugset / Trial / NCT01280149

Reduction of IgE Antibody in Human Allergic Subjects

NCT01280149

Phase 1 Completed 40 enrolled Northwestern University
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to determine whether a neuropeptide, substance P, when injected along with an allergen, such as ragweed, can reduce allergic reactivity.

Timeline

Start
2011-01
Primary completion
2017-06-20
Completion
2017-06-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Substance P Small molecule